$99B
$890 Million
0.02% of portfolio
12,904
Q1 2024
Reduced 11.92%
$74.7B
$874 Million
0.02% of portfolio
26,772
Q2 2023
Reduced 9.57%
$48.5B
$936 Million
0.02% of portfolio
7,069
Q4 2023
Reduced 16.87%
-
$1.04 Billion
0.02% of portfolio
-
Q4 2024
Added 27.5%
$87.9B
$884 Million
0.02% of portfolio
2,673
Q1 2024
Added 2.85%
$45.7B
$847 Million
0.02% of portfolio
5,823
Q2 2024
Reduced 1.22%
$10.2B
$985 Million
0.02% of portfolio
55,236
Q1 2024
Added 32.73%
$11.6B
$866 Million
0.02% of portfolio
7,542
Q4 2023
Reduced 2.02%
$4.86B
$947 Million
0.02% of portfolio
12,843
Q2 2025
New
$36.7B
$759 Million
0.02% of portfolio
6,194
Q1 2024
Reduced 26.98%
$10.8B
$1.04 Billion
0.02% of portfolio
48,484
Q4 2024
Reduced 3.53%
$77.6B
$850 Million
0.02% of portfolio
11,436
Q1 2024
Reduced 38.22%
$4.12B
$1.24 Billion
0.02% of portfolio
31,253
Q4 2024
Reduced 8.61%
$31B
$981 Million
0.02% of portfolio
1,834
Q2 2024
Reduced 8.23%
$95.9B
$1.15 Billion
0.02% of portfolio
24,821
Q1 2024
Reduced 1.87%
$65.4B
$954 Million
0.02% of portfolio
3,567
Q1 2024
Reduced 70.73%
$54.6B
$1.15 Billion
0.02% of portfolio
35,147
Q1 2024
Added 16.3%
$35.6B
$1.12 Billion
0.02% of portfolio
11,142
Q1 2024
Reduced 41.24%
$138B
$1.06 Billion
0.02% of portfolio
47,243
Q1 2024
Reduced 6.85%
-
$375 Million
0.01% of portfolio
-
Q4 2024
Added 49.41%
$32.9B
$288 Million
0.01% of portfolio
1,178
Q1 2024
Reduced 95.25%
Bentley Systems Incorporated
-
$284 Million
0.01% of portfolio
-
Q1 2023
Added 400.0%
$87.3B
$456 Million
0.01% of portfolio
909
Q1 2024
Reduced 23.44%
$34.2B
$301 Million
0.01% of portfolio
1,554
Q4 2024
Added 47.75%
$23.3B
$733 Million
0.01% of portfolio
3,361
Q2 2024
Reduced 38.59%
-
$482 Million
0.01% of portfolio
-
Q1 2024
Reduced 2.27%
$41.1B
$737 Million
0.01% of portfolio
4,387
Q2 2024
Reduced 28.45%
$37.4B
$599 Million
0.01% of portfolio
25,314
Q3 2023
Sold Out
$2.93B
$265 Million
0.01% of portfolio
5,200
Q1 2024
Added 164.91%
-
$360 Million
0.01% of portfolio
-
Q4 2024
Sold Out
$77.2B
$256 Million
0.01% of portfolio
4,082
Q1 2024
Added 30.35%
$13B
$550 Million
0.01% of portfolio
79,401
Q1 2024
Reduced 35.27%
$47.4B
$398 Million
0.01% of portfolio
34,771
Q4 2023
Reduced 69.62%
$21.2B
$715 Million
0.01% of portfolio
3,200
Q1 2024
Added 7.32%
$58B
$472 Million
0.01% of portfolio
2,346
Q2 2023
Sold Out
$28.1B
$424 Million
0.01% of portfolio
10,102
Q1 2024
Reduced 71.91%
$994M
$634 Million
0.01% of portfolio
87,979
Q1 2025
Reduced 72.77%
$56.1B
$427 Million
0.01% of portfolio
1,310
Q4 2024
Reduced 13.13%
$12.4B
$294 Million
0.01% of portfolio
1,488
Q4 2024
Reduced 10.23%
$19.1B
$298 Million
0.01% of portfolio
5,304
Q4 2023
Reduced 20.46%
-
$283 Million
0.01% of portfolio
-
Q2 2025
New
$16.1B
$530 Million
0.01% of portfolio
6,021
Q4 2024
Sold Out
$28B
$560 Million
0.01% of portfolio
8,875
Q1 2025
Reduced 10.55%
$19.3B
$361 Million
0.01% of portfolio
6,447
Q4 2024
Sold Out
Alnylam Pharmaceuticals Inc
-
$260 Million
0.01% of portfolio
-
Q4 2023
Added 150.0%
$42.9B
$475 Million
0.01% of portfolio
1,512
Q3 2023
Sold Out
$38.1B
$550 Million
0.01% of portfolio
8,596
Q2 2024
Reduced 20.39%
$37.8B
$349 Million
0.01% of portfolio
191
Q1 2024
New
-
$339 Million
0.01% of portfolio
-
Q4 2024
Added 100.0%
$35.5B
$746 Million
0.01% of portfolio
11,917
Q1 2024
Reduced 5.48%